⌘K

Home/Insiders/Axon Steven

AS

SEC Insider//CIK 0001720605

Axon Steven

CIK 00017206051 companyCRESTWOOD, KY

Transactions

5

Companies

1

Filings

2

CIK

0001720605

Recent Transactions

5 trades

Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2018-11-14$2.59/sh+11,500→ 50,110 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2018-11-14−11,500→ 348,389 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2018-02-20$2.59/sh+38,610→ 38,610 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2018-02-20+38,610→ 359,889 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2018-02-16+60,000→ 60,000 total

Companies

1

Apellis Pharmaceuticals, Inc.
Chief Business Officer
$APLS

Recent Filings

2

Address

C/O APELLIS PHARMACEUTICALS, INC. 6400 WESTWIND WAY, SUITE A

CRESTWOOD, KY, 40014

View on SEC.gov